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ABSTRACT 
Since metallic biomaterials used for bone replacement possess low bioactivity, the use of cell 
adhesive moieties is a common strategy to improve cellular response onto these surfaces. In 
recent years the use of recombinant proteins has emerged as an alternative to native proteins 
and short peptides owing to the fact that they retain the biological potency of native proteins, 
while improving their stability. In the present study, we investigated the biological effect of 
two different recombinant fragments of fibronectin, spanning the 8th-10th and 12th-14th type 
III repeats, covalently attached to a new TiNbHf alloy using APTES silanization. The 
fragments were studied separately and mixed at different concentrations and compared to a 
linear RGD, a cyclic RGD and the full-length fibronectin protein. Cell culture studies using 
rat mesenchymal stem cells demonstrated that low to medium concentrations (30% and 50%) 
of type III 8th-10th fragment mixed with type III 12th-14th fragment stimulated cell adhesion 
and proliferation compared to RGD peptides and the fragments separately. On the other hand, 
type III 12th-14th fragment alone or mixed at low volume percentages ≤ 50% with type III 8th-
10th fragment increased alkaline phosphatase levels compared to the other molecules. These 
results are significant for the understanding of the role of fibronectin recombinant fragments 
in cell responses and thus to design bioactive coatings for biomedical applications.  
 
KEYWORDS: Fibronectin; recombinant protein; cell adhesive peptides; mesenchymal stem 
cells; titanium alloy 
 
 
 
Page 2 of 41
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
1. INTRODUCTION 
Titanium (Ti) and Ti-based alloys have been traditionally used for bone implantation 
purposes.1 Despite the good biocompatible properties showed by these materials, there is a 
mismatch with bone elastic modulus, which is translated in a stress shielding effect.2 In a 
bone replacement scenario, the prosthesis shares the load and carrying capacity of bone. The 
loads applied to bone are reduced leading to a new loads distribution and eventually to bone 
resorption, which is a major cause of implant failure. Ductile metals such as Zr, Ta, Nb or Hf 
are used to stabilize the beta phase in Ti-alloys,3–5 which is the phase with lowest elastic 
modulus, and also because they possess osseoinductive properties.6 A particularly interesting 
Ti-based alloy is the TiNbHf ternary system. This system has shown interesting properties 
such as low elastic modulus, good biocompatibility and no cytotoxic effects.7,8 In this regard, 
we have recently developed the Ti25Nb21Hf alloy, which exhibited lower elastic modulus 
and higher wear resistance compared to Ti.9 
Despite the interesting biocompatibility and mechanical properties exhibited by TiNbHf 
alloys, these metallic biomaterials are not bioactive and thus do not promote osseointegration 
at an optimal rate, compromising in some circumstances the long-lasting stability of the 
implants. For this reason, in recent years several efforts have concentrated on the 
biofunctionalization of the biomaterials surface to improve their bioactivity and hence their 
osseointegration.10 In detail, the main goal of biofunctionalization is to generate an 
extracellular matrix (ECM)-like environment that positively influences the behaviour of 
osteoblast and bone precursors (i.e. mesenchymal stem cells, MSCs) and effectively guides 
bone growth.11,12 The ideal strategy is the use of native bone ECM proteins, such as collagen 
or fibronectin (FN), for coating the surfaces.13,14 
However, although these proteins retain their full biological functionality and specificity, 
they display low stability after functionalization along with many other drawbacks including 
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high production costs and immunogenicity, which have reduced their biomedical potential.11 
The use of ECM-derived synthetic peptides containing the functional sites of ECM proteins is 
an interesting approach to overcome these problems.10,11 The advantages of these motives in 
regards to ECM proteins are their higher stability, lower production costs and their capability 
to be synthetically tailored in composition for specific biological applications.  
In particular, integrin-binding sequences are of great interest since they regulate not only cell 
adhesion but also cell survival, proliferation and differentiation. This is illustrated by the cell 
adhesive arginine-glycine-aspartic acid (RGD) motif, which is present in many ECM proteins 
including FN, vitronectin, bone sialoprotein and osteopontin, and has been widely used to 
mimic cell/matrix interactions and improve the osteointegration of implant materials.10–12,15 
Nonetheless, short synthetic peptides are commonly less functional and specific than full-
length proteins due to the absence of complementary domains required for biological activity 
or inadequate conformation, both of which are crucial to trigger an appropriate cell 
response.16 To solve these problems, different approaches aiming at improving the activity 
and selectivity profile of integrin ligands have been followed:  cyclic peptides,17–19 
peptidomimetics,20–23 mixtures of peptides24–26  or peptide-based platforms.27 
The use of recombinant protein fragments for functionalizing surfaces has emerged as a 
potential strategy that combines the benefits of the aforementioned methods.28–31 Using 
recombinant DNA technology the signalling domain of an ECM protein can be engineered to 
retain crucial biological features such as the conformation and spacing of bioactive 
sequences, while reducing the antigenicity and improving the stability of native proteins. 
Noteworthy, fusion of more than one domain from the same protein or domains from 
different proteins can be assembled modulating different cell responses with only one 
molecule.32–34  
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FN is a well-known ECM protein that mediates many cellular processes like cell adhesion, 
migration, growth and differentiation.35 FN contains a region involved in cell adhesion 
located in the type III10 domain, which includes the above-mentioned RGD sequence. In 
addition, the type III9 domain contains the PHSRN (Pro–His–Ser–Arg–Asp) sequence, which 
strongly modulates and increases the binding affinity of RGD to α5β1 integrin.35,36  
Previous studies have demonstrated that the cell attachment site (CAS) recombinant fragment 
of FN, consisting of type III8-10 repeats or III7-10 enhances cell adhesion, proliferation and 
differentiation.28,37 Studies by Martino et al.31 demonstrated the good adhesion and 
osseoinduction potential of MSCs in contact with the FNIII9-10 fragment. Petrie et al.
30 
showed the capacity of the FN III7-10 fragment to increase osteoblastic differentiation and 
mineralization in vitro and enhanced implant osseointegration in a rat cortical bone model 
compared to RGD and fibronectin. In vivo studies by Agarwal et al. demonstrated that the FN 
III7-10 fragment promotes α5β1 integrin-dependent adhesion and osteogenic differentiation of 
hMSCs.38   
Besides the CAS, there is another region in FN, the C-terminal type III12-14 heparin-binding II 
(HBII) domain also crucially involved in cytoskeletal organization and focal adhesion 
formation. This HBII domain binds to proteoglycans, including heparan sulfate proteoglycans 
(HSPGs) such as syndecans.39 For instance, syndecan-4 has been described to play an 
important role in the regulation of the activation of several integrins through the HBII 
domain.40 Moreover, it has been shown that HB domains in FN enhance cell adhesion and 
proliferation of osteoblasts together with the CAS domain.39 Another important feature of the 
HBII domain was described by Martino et al.41 In his studies, its capability to sequester 
growth factors from different families was demonstrated. 
The present work aims to covalently functionalize a Ti25Nb21Hf alloy with FNIII 8-10 and 
FNIII 12-14 recombinant fragments alone or combined at different concentrations to elucidate 
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the importance of each fragment on the biological response for implant applications. These 
sequences have been compared to FN and two short synthetic RGD peptides (linear and 
cyclic, linRGD and cRGD, respectively). Cellular behaviour has been analysed in terms of 
cell adhesion, proliferation and differentiation using rat mesenchymal stem cells (rMSCs).   
2. MATERIALS AND METHODS 
2.1. TiNbHf alloy fabrication and preparation 
The alloy was fabricated as described in 9. Briefly, commercially pure (CP)-Ti, Nb (99.8% 
purity) and Hf (99.7% purity) were arc melted and vacuum homogenized. Bars of diameter 
10 mm were obtained by extrusion. TiNbHf alloy bars were cut in discs of 2 mm thickness 
and grinded with SiC papers of grit 320, 800, 1200 and 2500 (Struers, Spain). After grinding, 
the discs were mirror polished with colloidal silica (size particle 0.05 µm, ATM GmbH, 
Germany). Samples were cleaned in an ultrasound bath with cyclohexane, isopropanol, 
ethanol, deionized water and acetone (all chemicals were of the highest purity available from 
Sigma-Aldrich, USA). 
2.2. Recombinant FN fragments  
Recombinant DNA techniques were used to synthetize two different fragments of human FN: 
i) the Cell Attachment Site (CAS) sequence, spanning the 8th–10th type III repeats, and ii) 
the Heparin Binding II (HBII) sequence spanning the 12th–14th type III repeats. DNA 
extracted from SaOS-2 cells was specifically amplified by PCR using 5’-
GTCGACAAGTTCCTCCTCCCACTGACCT-3’ and 5’-
GCGGCCGCTTAATGGAAATTGGCTTGCTG-3’ (for CAS domain) or 5’- 
GTCGACAAGCTATTCCTGCACCAACTGA-3’ and 5’- 
GCGGCCGCTGTCTTTTTCCTTCCAATCAGG-3’ (for HBII domain). Each DNA fragment 
was digested with SalI and NotI (New England Biolabs, USA) and ligated into a pGEX-6P-1 
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plasmid (GE Healthcare, UK). The resulting constructs, containing CAS or HBII with a 
glutathione S-transferase (GST) tagging sequence at the amine terminus, were separately 
amplified in DH5α cells (Invitrogen, USA), purified and sequenced. Then, BL21 E.coli 
strains (Invitrogen) were separately transformed with the plasmids and streaked onto LB agar 
plates containing 100 µg/ml of ampicillin and incubated at 37 ºC overnight. Colonies were 
isolated and dynamically cultured in LB broth (Sigma-Aldrich) with 100 µg/ml of ampicillin 
at 37 ºC until they reached an OD600=0.6. Expression of the fragments was induced by 
addition of 1 mM IPTG. After 4 h, cells were harvested by centrifugation and lysed by 
sonication. Then, 20% Triton X-100 was added and the suspension was incubated at 4 ºC for 
30 min under mild agitation. The suspension was then centrifuged and the supernatant was 
purified at 4 °C using GSTrap affinity columns (GE Healthcare) in an ÄKTA purifier (GE 
Healthcare). GST tag was on-column removed by cleavage with HRV3C Protease (Sigma-
Aldrich) in Cleavage Buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM 
dithiothreitol, pH 7.0). Purity was verified to be >95% by SDS-PAGE. Protein concentrations 
were determined by BCA assay (Pierce, Thermo Fisher Scientific, USA). 
2.3. Synthesis of linear RGD peptide (linRGD) 
The linear peptide MPA-Ahx-Ahx-Ahx-Gly-Arg-Gly-Asp-Ser-OH (linRGD) (Ahx: 
aminohexanoic acid; MPA: 3-mercaptopropionic acid) was manually synthesized by solid-
phase peptide synthesis (SPPS) following the Fmoc/tBu strategy42 and using 2-chlorotrityl 
chloride resin (CTC, 200 mg, 1.6 mmol/g) (Iris Biotech GmbH, Germany) as solid support. 
Fmoc-L-amino acids were obtained from Iris Biotech GmbH and coupling reagents from 
Sigma-Aldrich and Luxembourg Industries Ltd. (Israel). All other chemicals and solvents 
were acquired from Sigma-Aldrich, Alfa Aesar (Germany) and SDS (France). The first amino 
acid was incorporated by sequential addition of Fmoc-Ser(tBu)-OH (1 equiv) and N,N-
diisopropylethylamine (DIEA) (10 equiv). After 1 h under stirring the resin was capped with 
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MeOH (0.8 mL/g of resin).  The Fmoc group was removed by treatment with piperidine/N,N-
dimethylformamide (DMF) (1:4, v/v) and the following coupling reactions were carried out 
with Fmoc-L-amino acids (4 equiv), Oxyma Pure (4 equiv) and N,N’-
diisopropylcarbodiimide (DIC) (4 equiv) in DMF for 45 min. The efficiency of each reaction 
was monitored using the Kaiser test and by analytical HPLC analysis (Waters Alliance 2695 
chromatography system) (Waters, USA). After synthesis, the peptide was cleaved from the 
solid support with concomitant deprotection of the side chain protecting groups. To this end, 
the resin was washed with dichloromethane (DCM), dried, and treated with trifluoroacetic 
acid (TFA)/H2O/triisopropylsilane (TIS) (95:2.5:2.5) for 1.5 h. The peptide was then 
precipitated with cold diethyl ether, centrifuged and washed twice with diethyl ether. This 
crude peptide was dissolved in H2O/MeCN (1:1, v/v) and lyophilized. Purification of the 
peptide was achieved by semi-preparative HPLC (Waters Delta 600 instrument) using linear 
gradients from 0 to 10 % MeCN over 2 min and 10 to 30 % MeCN over 10 min. The purified 
peptide was characterized by analytical HPLC (10 to 40 % MeCN over 8 min, tR = 4.227 
min) and MALDI-TOF (Applied Biosystems, USA) (m/z calcd. for C38H67N11O13S: 917.46, 
found: 918.30 [M+H]+; 940.28 [M+Na]+); 956.25 [M+K]+). 
2.4. Synthesis of cyclic RGD peptide (cRGD) 
The cyclic peptide MPA-Ahx-Ahx-Ahx-cyclo(-RGDfK-) (cRGD) was synthesized as 
previously described19,43,44. In brief, the thiol-protected anchor MPA(Trt)-Ahx-Ahx-Ahx-OH 
(1 equiv), 1-hydroxy-7-azabenzotriazole (HOAt) (1.2 equiv) and N-[(dimethylamino)-1H-
1,2,3-triazolo[4,5-b]pyridino-1-ylmethylene]-N-methylmethanaminium hexafluorophosphate 
(HATU) (1.2 equiv) were dissolved in anhydrous DMF (0.022 mM) and pre-activated for 3 h 
at room temperature in the presence of DIEA (5 equiv). Next, cyclo(-R(Pbf)GD(OtBu)fK-) (1 
equiv) dissolved in anhydrous DMF was added to the reaction mixture and allowed to react 
under stirring overnight at room temperature. After reaction, DMF was evaporated to 
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dryness, a saturated solution of NaHCO3 was added and the crude product was extracted with 
EtOAc thrice. The organic layer was washed with brine, dried with Na2SO4 and evaporated. 
The peptide was next treated with TFA/H2O/TIS (95:2.5:2.5) for 1.5 h. The peptide was 
finally precipitated with cold anhydrous diethyl ether, washed twice with this solvent and 
lyophilized. Semi-preparative HPLC purification (linear gradients from 0 to 10 % MeCN 
over 2 min and 10 to 40 % MeCN over 15 min) yielded the peptide as a white powder. The 
purified peptide was characterized by analytical HPLC (10 to 40 % MeCN over 8 min, tR = 
6.578 min) and MALDI-TOF (m/z calcd. for C48H78N12O11S: 1030.56, found: 1031.39 
[M+H]+; 1053.37 [M+Na]+); 1069.35 [M+K]+) . 
2.5. Sample biofunctionalization 
2.5.1. Silanization 
Samples were silanized in order to covalently attach the molecules to the substrate. TiNbHf 
samples and Quartz Crystal Microbalance with Dissipation Monitoring (QCM-D) Ti sensors 
(QSX310, Q-Sense, Sweden) were first cleaned in an ultrasound bath with cyclohexane, 
isopropanol, ethanol, deionized water and acetone, and then cleaned and activated with 
oxygen plasma for 5 min at a 12 MHz frequency in an Expanded Plasma Cleaner PDC-002 
(Harrick Scientific Corporation, USA). Then, samples were immersed in a 0.08 M solution of 
(3-aminopropyl)triethoxysilane (APTES, Sigma-Aldrich) in toluene (Sigma-Aldrich) at 70 ºC 
for 1 h under agitation in an inert atmosphere. After silanization, samples were ultrasonicated 
in toluene for 5 min and cleaned with toluene (3x), acetone (1x), isopropanol (3x), distilled 
water (3x), ethanol (3x) and acetone (3x). Subsequently aminosilanized samples were 
immersed in a 7.5 mM solution of N-succinimidyl-3-maleimidepropionate (SMP) in DMF for 
1 h under agitation at room temperature. The cross-linked samples were rinsed in DMF (3x), 
acetone (1x), distilled water (10x), ethanol (3x) and acetone (3x) and dried with nitrogen. 
 
Page 9 of 41
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
2.5.2. Molecules immobilization 
linRGD and cRGD were used at a concentration of 100 µM and CAS and HBII were used at 
a concentration of 100 µg/ml (concentrations optimized in previous studies in our group). FN 
(Sigma-Aldrich) was used at a 50 µg/ml concentration. Solvent for all molecules was 
phosphate buffered saline (PBS, Invitrogen).  
Ti25Nb21Hf silanized samples were incubated overnight with a 100 µl drop of linRGD, 
cRGD, FN, CAS, HBII, respectively, or combinations of different proportions of CAS and 
HBII (30:70, 50:50 or 70:30 respectively, v/v). After incubation, samples were rinsed in PBS 
(x3) and blocked with 1% bovine serum albumin (BSA, Sigma-Aldrich) in PBS for 30 min. 
Samples were sterilized by immersion in ethanol for 30 min followed by 3 rinses in PBS. 
2.6. Quartz crystal microbalance with monitoring dissipation (QCM-D) 
The QCM-D was used to study the biomolecules adsorption onto silanized Ti sensors. The 
QCM-D (D300, Q-Sense, Sweden) measurements were performed at 37⁰C by monitoring 
changes in frequency, ∆f (Hz), and dissipation, ∆D (×10-6), in real-time using Qsoft software 
(Q-Sense). All raw data was analyzed using QTools software (Q-Sense). Frequency and 
dissipation curves were fitted to a Voigt viscoelastic model to yield relevant mass, thickness, 
and kinetic information. The description of the Voigt model and details on its implementation 
using a QCM-D are reported elsewhere.45,46 
Monitoring of the adsorption was conducted first by completely stabilizing the baseline with 
PBS for 30-60 min. Then, the biomolecule of study was introduced at a concentration 
specified in section 2.5.2, and maintained in the sensor chamber for 60 min. Finally, the 
biomolecules weakly bound to the surface were rinsed with PBS for 10 min. 
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2.7. X-ray photoelectron spectroscopy (XPS) 
XPS measurements were used to analyze the chemical composition of the samples after 
biomolecule immobilization. To this end, samples were silanized and coated as explained in 
section 2.5, and analyzed using an XPS system (SPECS Surface Nano Analysis GmbH, 
Berlin, Germany) equipped with a Mg anode XR50 source operating at 150 W and a Phoibos 
150 MCD-9 detector. Detector pass energy was fixed at 25 eV with 0.1 eV steps to record 
high resolution spectra at a pressure below 7.5 × 10−9mbar. Data was analyzed using 
CasaXPS software (Version 2.3.16, Casa Software Ltd., Teignmouth, UK). Binding energies 
were calibrated with the C1s signal located at 284.8 eV.  
 
2.8. Cell culture 
rMSCs were extracted from femurs of young Lewis rats and expanded in Advanced DMEM 
supplemented with 10% fetal bovine serum (FBS), 20 mM HEPES buffer solution, 
penicillin/streptomycin antibiotics (50 U/ml and 50 µg/ml, respectively), 2 mM L-glutamine 
(all from Invitrogen) at 37 ºC with 5% CO2 and 95% relative humidity. Cells from passage 5 
were used in all the experiments. 
2.9. Cell adhesion 
Cells (10.000 cells/sample) were seeded in each sample with serum-free medium and allowed 
to adhere for 4 h. Then, cells were rinsed with PBS (x3) and lysed with 300 µl of Mammalian 
Protein Extraction Reagent (M-PER, Thermo Fisher, USA). The number of cells adhered was 
determined using the Cytotoxicity Detection Kit PLUS (LDH) (Roche, USA) following the 
manufacturer’s instructions. The lactate dehydrogenase (LDH) activity was measured 
spectrophotometrically at 492 nm in a PowerWave HT microplate reader (Bio-Tek, USA). A 
calibration curve with decreasing number of cells was performed to express the results as cell 
number. 
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2.10. Cell spreading 
Cells (25.000 cells/sample) were seeded in each sample with serum-free medium and fixed 4 
h after seeding with 4% paraformaldehyde (Sigma-Aldrich) for 30 min. Fixed cells were 
permeabilized with 0.05% Triton X-100 in PBS at room temperature for 20 min and washed 
with 20 mM glycine in PBS (x3). Then samples were blocked with 1% BSA in PBS and 
incubated for 30 min. Next, cells were incubated with mouse anti-vinculin (1:100; Invitrogen) 
for 1h and rinsed with 20 mM glycine in PBS. Afterwards, samples were incubated with 
Alexa Fluor ® 488 goat anti-mouse antibody (1:1000; Invitrogen) and TRITC-phalloidin 
(1:300; Invitrogen) in the dark for 1 h. After incubation, samples were washed with 20 mM 
glycine in PBS (x3) and nuclei were counterstained with DAPI (1:1000; Invitrogen). Finally, 
samples were mounted in Mowiol® 4-88 (Sigma-Aldrich) before visualizing in an E600 
fluorescence microscope (Nikon Corp., Japan). Five images at 10X magnification from 
different areas of each sample were acquired and cell spreading was determined measuring 
the area of the cells using ImageJ software (National Institute of Health, USA).  
2.11. Cell proliferation 
Cells were seeded in serum-free medium at a density of 10.000 cells/sample. After 4 h, 
medium was aspirated, and cells were cultured for 7 days, 14 days and 21 days in complete 
medium. After each incubation period, cells were rinsed in PBS (x3) and lysed with 300 µl of 
M-PER. The number of cells adhered was determined using the Cytotoxicity Detection Kit 
PLUS
 (LDH) as described above. 
2.12. Cell differentiation 
Lysed cells from the proliferation assay were also used for alkaline phosphatase (ALP) 
detection using the SensoLyte® pNPP Alkaline Phosphatase Assay Kit (AnaSpec Inc., USA) 
following the manufacturer’s guidelines. Reactions were incubated at 37 ºC for 30 min. After 
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incubation, values of absorbance were read in a PowerWave HT microplate reader at 405 nm. 
A calibration curve was prepared using purified ALP from the kit. Results were normalized 
versus cell number and time of incubation. 
2.13. Statistical analysis 
Experiments were performed in duplicate using three replicates per each group. All data are 
presented as mean values ± standard deviations. A non-parametric Kruskal-Wallis test 
followed by Mann-Whitney test with Bonferroni correction was used to determine statistical 
significant (p-value<0.05) differences between the means of the different groups. 
 
3. RESULTS 
3.1. Physicochemical characterization 
3.1.1 QCM-D 
The thickness and surface mass density of the adlayer of immobilized biomolecule on 
silanized Ti sensors determined by QCM-D analysis is shown in Table 1. Figure S1 
(supplementary material) shows the changes in frequency and dissipation over time recorded 
during the adsorption of the biomolecules. In all cases, the frequency rapidly decreased after 
injection, reaching values of saturation after 10 and 15 min for the peptides and protein 
fragments, respectively. Moreover, dissipation coefficients showed small changes during the 
adsorption of peptides, while very high values were reached for HBII and to a slightly lower 
extent for the CAS protein fragment. The final adsorbed mass was considerably higher for the 
protein fragments (609.1 ng/cm2 for CAS, 823.8 ng/cm2 for HBII) than for the peptides 
(220.1 ng/cm2 for linRGD and 200.0 ng/cm2 for cRGD). 
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3.1.2. XPS 
The analysis of the chemical composition of the surfaces by XPS is summarized in Table 2.  
In general, the presence of the biomolecules increased the percentage of C 1s and N 1s and 
decreased the observed amounts of O 1s, Si 2p and Ti 2p compared to control (Ctrol) non-
functionalized surfaces. These effects were more pronounced for the protein fragments (CAS 
and HBII) than for the peptides (linRGD and cRGD). 
3.2. Cell adhesion  
3.2.1. Number of cells adhered 
 The number of cells adhered onto each biofunctionalized surface (Fig. 1) differed depending 
on the immobilized molecule. Surfaces coated with linRGD, cRGD, CAS or HBII, 
respectively, showed a significant improvement on cell adhesion compared to FN (p<0.05). 
There were no statistical differences on cell numbers between the peptides and the protein 
fragments.  On the other hand, the different combinations of CAS and HB II fragments 
triggered different cell adhesion responses. Low concentrations of CAS (30% and 50%) 
stimulated an adhesion similar to that of FN, whilst a higher concentration (70%) originated a 
response comparable to that of linRGD, cRGD, CAS or HBII fragments alone.   
3.2.2. Cell spreading 
The area of cells adhered on the different biofunctionalized surfaces is shown in Fig. 2. The 
spreading obtained for cells in contact with linRGD and HBII respectively, was statistically 
lower (p<0.05) than that obtained for cells in contact with FN, cRGD and CAS. When both 
CAS and HB II recombinant fragments were mixed, the proportion of each of the two 
fragments influenced cell spreading. Low percentages (30% and 50%) of CAS induced 
values of cell spreading close to that found on FN-coated surfaces, whereas higher values of 
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CAS (70%) led to lower projected cell areas, with values similar to those of the linear RGD 
peptide and the HBII fragment alone.    
3.2.3. Cell morphology 
The formation of actin stress fibers (in red) was stimulated by linRGD (Fig. 3B), cRGD (Fig. 
3C) and CAS (Fig. 3D), although structures resembling focal contacts were not seen in the 
cells in contact with these biomolecules. Cells in contact with HBII (Fig. 3E) were not able to 
generate neither actin filaments nor focal adhesions and showed ruffled borders. Noteworthy, 
when both CAS and HBII were mixed with low percentages of CAS (Figs. 3F and 3G) cells 
showed a cytoskeleton conformation closer to that of FN compared to the other biomolecules, 
whereas the presence of CAS in high percentage (Fig. 3H) showed a cytoskeleton similar to 
the CAS fragment alone. 
3.3. Cell proliferation  
The proliferation of rMSCs on the different biofunctionalized substrates after 4 h, 7 days, 14 
days and 21 days in culture is shown in Fig. 4. Although cells cultured with linRGD, cRGD, 
CAS or HBII, respectively, supported cell proliferation within the initial 7 days of incubation, 
the number of cells on these surfaces did not reach the values obtained with FN coating, 
which showed the highest values of cell growth at 21 days. Noteworthy, when CAS and HBII 
recombinant fragments were mixed using less than 70% of CAS, the proliferation levels were 
closer to FN samples. In contrast, for higher percentages of CAS fragment proliferation rates 
were similar to short peptides or recombinant fragments separately. 
3.4. Cell differentiation  
Fig. 5 shows the ALP activity levels of rMSCs after 7, 14 and 21 days in culture. The first 7 
days in culture, ALP levels for cells cultured on HBII and high percentage of CAS (70%) 
were significantly higher compared with FN and the other molecules, which showed levels of 
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ALP equivalent to that of FN. After two weeks in culture, ALP from cRGD, CAS and CAS 
(50%) was reduced whilst the other surfaces showed similar levels compared with FN and 
between them. However, cells cultured on cRGD or CAS fragment exhibited an increase on 
ALP levels 21 days after seeding, reaching levels similar to those of FN. Noteworthy, HBII-
coated surfaces stimulated significantly higher ALP levels than linRGD, cRGD, CAS and FN 
at all time points, reaching the highest levels of ALP production after 21 days of incubation. 
Combination of the HBII with a high percentage of CAS (70%) maintained this high ALP 
expression. In contrast, ALP levels were significantly reduced when HBII was mixed with 
lower concentrations of CAS (30% and 50%). 
4. DISCUSSION 
One approach to improve osseointegration in metallic implants is the immobilization of 
bioactive molecules on their surface. Such modifications are usually achieved by 
physisorption or covalent bonding. Physisorption is a non-covalent method based on Van der 
Waals interactions and hydrogen bonds, which are weak and unstable interactions. In 
contrast, the use of silane chemistry is a preferred and well-extended method for covalently 
bounding bioactive molecules onto metallic surfaces as it provides a strong and stable 
binding on the surfaces.22,47 In this regard, APTES has been extensively used for surface 
functionalization purposes and demonstrated its suitability for the immobilization of bioactive 
molecules onto Ti22 and TiNbHf alloy.48 Moreover, in a recent study we demonstrated that 
the use of APTES provides a more homogenous layer of biomolecule attachment in both Ti 
and TiNbHf alloy compared to physisorption.49 Hence, in the present work APTES was 
chosen as linker molecule to immobilize the different bioactive molecules onto a recently 
developed low modulus TiNbHf alloy.  
As previously introduced, the binding of synthetic RGD peptides to Ti surfaces and TiNbHf 
alloys using this silane has been recently characterized, and yielded a dense and homogenous 
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layer of peptide on the surfaces.49 The number and density of molecules immobilized on 
these surfaces with this method has been reported in a large number of previous studies.50,51 
However, no literature was available on the relative adsorption kinetics of the CAS and HBII 
fragments on TiNbHf via APTES. QCM-D results indicated a successful attachment of both 
proteins and peptides on the Ti sensors, reaching values of saturation after 10 min and 15 min 
of incubation, respectively. Rinsing in PBS resulted in minor protein detachment, proving the 
stability of the coatings. The amount of adsorbed protein was slightly different for each 
fragment (i.e. HBII adsorbed mass was 1.3 fold higher than that of CAS). This observation 
might be attributed to the distinct conformation and chemical sequence of the proteins, which 
in turn results in different values of protein binding. As expected, surface mass density was 
lower for peptides compared to protein fragments. The amount of adhered linRGD was 
slightly higher than cRGD but differences were not statistically significant. Dissipation shift 
plots indicated that during HBII protein adsorption, water was incorporated and trapped in the 
layer of protein, as seen in the increasing ∆D. CAS protein layer was less viscoelastic and 
both peptide adsorbed layers were more rigid compared to the HBII protein fragments layer.  
XPS data confirmed QCM-D results and showed a successful biofunctionalization of the 
surfaces. The observed increases in C 1s, and especially in N 1s, are common indicators of 
biomolecule attachment (i.e. amide bonds).22,27,50,51 The reduction in the detectable signals of 
Ti 2p, O 1s, and Si 2p is also consistent with the presence of biomolecules, which mask the 
detection of Ti oxide and the silane layer. The binding of the protein fragments yielded the 
highest variations in chemical composition (e.g. the percentage of N 1s) in comparison to the 
RGD peptides. This observation is well in agreement with QCM-D values, which indicated 
that the amount of proteins bound to the surfaces was higher than that of the peptides.  
The interaction of cells with the different functionalized surfaces exhibited substantially 
different behaviours. Both recombinant FN fragments, CAS and HBII, stimulated better cell 
Page 17 of 41
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
adhesion than the whole FN, and similarly to RGDs. The higher activity of a recombinant 
FNIII7-10 fragment compared to plasma human FN has been previously described by the 
group of García30 and associated with an enhanced affinity for integrin α5β1. The higher 
number of attached cells observed for RGD peptides could also be attributed to a higher 
availability of cell adhesive motifs per area compared to native FN. Although previous 
studies demonstrated better cell adhesion on CAS fragment than on RGDs,28–30 these 
differences tend to disappear in saturated surface densities.28  Noteworthy, HBII also 
stimulated high cell adhesion numbers. This may be explained by the fact that cell surface 
HSPGs may act as receptors for the HB fragment52,53 and that integrin receptors α4β1 and 
αvβ5 may interact with specific sequences in this region of FN.52,54 
Although the number of cells was high in both FN fragments and RGDs, these cell adhesive 
motifs were not enough to stimulate cell spreading to similar levels than the native FN. In 
addition, the number of focal adhesions on these surfaces was lower compared to FN, 
suggesting that their formation depends on the interaction of cell adhesion sequences with 
other binding sites present in FN.55 This scenario completely changed when both recombinant 
FN fragments were mixed on the same surface. Although the number of cells increased while 
CAS concentration was incremented, cellular spreading, cytoskeletal organization and focal 
adhesion formation were improved with higher concentrations of HBII (≥50%). The observed 
critical biological role of the HBII domain is due to the presence of actin-organizing elements 
located in the type III13 repeat that stimulate the formation of focal adhesions.
55 In this study 
we have shown that the HBII fragment alone does not support cell spreading and cytoskeletal 
formation on the surfaces, however, in combination with small percentages of the CAS 
domain effectively stimulates the formation of stress fibers and focal contacts, reaching cell 
morphologies similar to FN.54,56,57 
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Integrin mediated adhesion plays a major role in the regulation of cell proliferation, since it 
stimulates crucial regulatory pathways of cell growth.58 However, proliferation not only 
depends on cell adhesive mechanisms but also on the interaction with soluble growth factors. 
The growth factor receptor signalling is moreover highly regulated by integrin expression and 
activity.59,60 In the present study, RGDs and the recombinant FN fragments did not induce 
cell proliferation at levels comparable to that of full-length FN, probably due to the lack of 
cooperation between adhesion and growth factor signalling. In contrast, the combination of 
the CAS with high concentrations of the HBII domain (≥ 50%) effectively improved 
proliferation of rMSCs. This could be attributed to the fact that besides the cell adhesion 
cooperative activity, HBII may also act as a growth factor binding domain. This enhancement 
in cell proliferation was also observed in previous studies by Kim et al.53 and Martino et al.,33   
although in their studies a molecule containing both CAS and HBII fragments fused was used 
instead.  
Finally, the stimulation of MSCs to differentiate into the osteoblastic lineage, also known as 
osseoinduction, is a critical step to ensure the biomaterial osseointegration. The secretion of 
ALP has been widely used as a marker for osteoblastic differentiation. In the present study, 
surface functionalization with a synthetic linRGD peptide was enough for stimulating rMSCs 
differentiation despite the low integrin-specificity described for linear peptides.36,61 
In the present study, surface functionalization with a synthetic linRGD peptide was enough 
for stimulating rMSCs differentiation. However, presentation of the RGD motif in a cyclic 
conformation reduced the expression of ALP levels. This result should not come as a surprise 
because cRGD shows a higher specificity than linRGD for integrins αvβ3 and αvβ5, but not 
towards α5β1, which is well known to induce osteogenic differentiation.62,63 Noteworthy, the 
presence of HBII yielded the highest levels of ALP activity probably due to the 
aforementioned capacity to bind diverse growth factors, which may include BMP-2 and 
Page 19 of 41
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
BMP-7 present in the serum.41 However, the combination of HBII and CAS fragments 
yielded unexpected results: whereas low percentages of HBII retained high values of ALP 
expression (CAS-HBII 70:30) higher amounts reduced this activity (CAS-HBII 50:50 and 
CAS-HBII 30:70) (Fig. 5).    
The equimolar presentation of CAS and HBII (50:50) should support similar biological 
profiles than full length FN. As a matter of fact, comparable cell responses were observed in 
terms of cell spreading, cytoskeleton formation and proliferation (Fig. 6). In this case, the 
reduced osteogenic capacity could probably respond to two factors: an insufficient quantity of 
HBII motifs available for growth factor interaction or the absence of other regulatory 
sequences present in FN, which may account for the osteogenic activity of the native protein. 
It was even more intriguing that an increase in the proportion of HBII (CAS-HBII 30:70) did 
not stimulate osteoblastic differentiation. We hypothesized that the reduced amount of CAS 
fragment available for integrin binding would not be enough for generating stable cellular 
adhesions and focal contacts, thereby engaging part of the HBII fragments in cell 
adhesion/cytoskeleton organization. This would explain why even if the proportion of CAS is 
reduced in the mixture CAS-HBII (30:70), the other parameters of cell behavior remain 
comparable to those of FN (Fig. 6). This “co-adhesive” role for HBII would, in turn, diminish 
its capacity to sequester growth factors and thus its osteogenic activity. Only when a larger 
amount of HBII is present (HBII alone) both an adhesive and an osteogenic effect can be 
maintained.  
This hypothesis could also explain the opposite situation (CAS-HBII 70:30). In this context, 
the high amount of CAS would be sufficient to efficiently stimulate cell adhesion and 
cytoskeleton organization. This would keep a higher number of HBII fragments free for 
interaction with growth factors increasing the ALP levels.  
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5. CONCLUSIONS 
In the present study cell response to functionalised Ti25Nb21Hf alloy with two different 
recombinant FN fragments was studied. The results demonstrate that the mixture of CAS and 
HBII fragments improves cellular behaviour compared to fragments alone or synthetic RGD 
peptides, being a promising strategy for biomaterial implantation purposes. This response 
may be modulated depending on the percentage of each fragment.  
When dealing with combinations of molecules that are bifunctional and/or share a similar 
biological function, it is important to highlight that reducing the percentage of one of the 
bioactive molecules in the mixture can modify the biological profile of the other one. In the 
present study, we observed that the reduction on the amount of cell adhesive motifs (CAS) in 
the mixture was accompanied with a decrease in the osteogenic activity of the HBII fragment. 
We hypothesized that this effect was attributed to the fact that the low percentage of CAS 
engaged HBII in cell adhesive processes, thus reducing its capacity to interact with growth 
factors and hence its osteogenic capacity. 
Therefore, it should be taken into account that the equimolar presentation of two bioactive 
molecules may not always be an optimal approach when these molecules have partially 
overlapping biological roles. In these instances, the study of different percentages of each 
motif is recommended.  
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TABLES 
Table 1. QCM-D study of the thickness and surface mass density of the bound biomolecules 
to silanized Ti sensors calculated using the Voigt model.  
Biomolecules Thickness (nm) Surface mass density (ng/cm
2
) 
CAS 5,54 (±0,09) 609,14 (±10,19) 
HBII 7,49 (±0,13) 823,80 (±14,00) 
linRGD 2,00 (±0,17) 220,12 (±9,17) 
cRGD 1,82 (±0,14) 200,01 (±14,98) 
 
Table 2. Surface chemical composition (expressed as atomic percentages) of the 
biofunctionalized samples by XPS.  
C 1s N 1s O 1s Si 2p Ti 2p 
Ctrol 22,96 (± 1.87) 0,76 (± 0.19) 56,25 (± 1.45) 0,49 (± 0.08) 19,57 (± 0.15) 
CAS 47,63 (± 0.13) 10,57 (± 0.25) 31,93 (± 0.04) 3,01 (± 0.06) 6,87 (± 0.23) 
HBII 46,45 (± 1.48) 10,26 (± 0.53) 32,85 (± 1.22) 3,66 (± 0.08) 6,78 (± 0.72) 
linRGD 32,16 (± 0.42) 4,82 (± 0.03) 46,31 (± 0.33) 4,82 (± 0.33) 11,91 (± 0.28) 
cRGD 34,77 (± 1.07) 5,33 (± 0.05) 43,55 (± 0.76) 5,53 (± 0.04) 10,83 (± 0.30) 
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FIGURE CAPTIONS 
Fig. 1. Adhesion of rMSCs onto Ti25Nb21Hf alloy biofunctionalized with the different 
biomolecules after 4 h of culture.  Letter “a” indicates study groups with no statistical 
differences with FN. Letter “b” indicates study groups with statistically significant 
differences compared to FN. 
Fig. 2. Spreading of rMSCs onto Ti25Nb21Hf alloy biofunctionalized with the different 
biomolecules after 4 h of culture. Letter “a” indicates study groups with no statistical 
differences with FN. Letter “b” indicates study groups with statistically significant 
differences compared to FN. 
Fig. 3. Representative high magnification images (60x) of rMSCs spreading and morphology 
after 4h in culture with FN (A), linRGD (B), cRGD (C), CAS (D), HB II (E), CAS-HBII 
30:70 (F), CAS-HBII 50:50 (G) and CAS-HBII (H) biofunctionalized surfaces.  Scale bar 20 
µm. 
Fig. 4. Proliferation of rMSCs onto Ti25Nb21Hf alloy biofunctionalized with the different 
biomolecules. At each time, “a”, “c”, “g” and “k” indicates no statistical differences 
compared to FN while distinct letters denote statistical differences to FN and between 
conditions. 
Fig. 5. ALP activity of rMSCs onto Ti25Nb21Hf alloy biofunctionalized with the different 
biomolecules. At each time, “a”, “c” and “e” indicates no statistical differences compared to 
FN while distinct letters denote statistical differences to FN and between conditions. 
Fig. 6. Summary of cell responses to functionalized surfaces with FN, different mixtures of 
CAS and HBII fragments (30:70, 50:50 and 70:30) and CAS and HBII fragments alone. 
Biomolecules with similar responses were grouped by colors for better interpretation of 
results. 
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Fig. 1. Adhesion of rMSCs onto Ti25Nb21Hf alloy biofunctionalized with the different biomolecules after 4 h 
of culture.  Letter “a” indicates study groups with no statistical differences with FN. Letter “b” indicates study 
groups with statistically significant differences compared to FN.  
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Fig. 2. Spreading of rMSCs onto Ti25Nb21Hf alloy biofunctionalized with the different biomolecules after 4 h 
of culture. Letter “a” indicates study groups with no statistical differences with FN. Letter “b” indicates study 
groups with statistically significant differences compared to FN.  
73x63mm (300 x 300 DPI)  
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Fig. 3. Representative high magnification images (60x) of rMSCs spreading and morphology after 4h in 
culture with FN (A), linRGD (B), cRGD (C), CAS (D), HB II (E), CAS-HBII 30:70 (F), CAS-HBII 50:50 (G) and 
CAS-HBII (H) biofunctionalized surfaces.  Scale bar 20 µm.  
42x65mm (300 x 300 DPI)  
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Fig. 4. Proliferation of rMSCs onto Ti25Nb21Hf alloy biofunctionalized with the different biomolecules. At 
each time, “a”, “c”, “g” and “k” indicates no statistical differences compared to FN while distinct letters 
denote statistical differences to FN and between conditions.  
58x40mm (300 x 300 DPI)  
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Fig. 5. ALP activity of rMSCs onto Ti25Nb21Hf alloy biofunctionalized with the different biomolecules. At each 
time, “a”, “c” and “e” indicates no statistical differences compared to FN while distinct letters denote 
statistical differences to FN and between conditions.  
59x42mm (300 x 300 DPI)  
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Fig. 6. Summary of cell responses to functionalized surfaces with FN, different mixtures of CAS and HBII 
fragments (30:70, 50:50 and 70:30) and CAS and HBII fragments alone. Biomolecules with similar 
responses were grouped by colors for better interpretation of results.  
84x40mm (300 x 300 DPI)  
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